Seoul, South Korea

Byung Oh Kwon

This inventor holds 1 USPTO granted patent. Top assignees: Pohang University of Science and Technology Foundation, Posco. Active years: 2010.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Byung Oh Kwon: Innovator in Alzheimer's Disease Research

Introduction

Byung Oh Kwon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical research, particularly in the context of Alzheimer's disease. His innovative work focuses on the interaction between amyloid proteins and vascular endothelial growth factor (VEGF).

Latest Patents

Kwon holds a patent titled "Methods of contacting β amyloid protein with VEGF." This invention relates to a VEGF polypeptide that binds to Aβ. Additionally, it encompasses a compound that sequesters Aβ and a compound that sequesters VEGF. The invention also includes a method for screening compounds that inhibit the binding of VEGF to Aβ, which is crucial for the prevention and treatment of Alzheimer's disease. Kwon has 1 patent to his name.

Career Highlights

Throughout his career, Byung Oh Kwon has worked with esteemed institutions such as the Pohang University of Science and Technology Foundation and Posco. His experience in these organizations has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Kwon has collaborated with notable colleagues, including Seung-Pil Yang and Sewook Hwang. Their joint efforts have furthered the understanding of the mechanisms involved in Alzheimer's disease and have contributed to the development of potential therapeutic strategies.

Conclusion

Byung Oh Kwon's innovative research and patent contributions are vital in the ongoing fight against Alzheimer's disease. His work exemplifies the importance of scientific inquiry and collaboration in addressing complex health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…